• No results found

Tingting Zhang Phone: EDUCATION Ph.D. in Pharmacoepidemiology

N/A
N/A
Protected

Academic year: 2021

Share "Tingting Zhang Phone: EDUCATION Ph.D. in Pharmacoepidemiology"

Copied!
6
0
0

Loading.... (view fulltext now)

Full text

(1)

Tingting Zhang

Tingting_zhang@brown.edu Phone: 1-401-863-3579 EDUCATION

Ph.D. in Pharmacoepidemiology 2007-2013 University of British Columbia Vancouver, Canada

Child & Family Research Institute

M.Sc. in Population and Public Health 2005-2006 Simon Fraser University Burnaby, Canada Faculty of Health Sciences

M.D. 2000-2005 Capital University of Medical Sciences Beijing, China

ACADEMIC AND PROFESSIONAL APPOINTMENTS

Assistant Professor 2016 – present Brown University School of Public Health,

Center for Gerontology & Health Care Research, Department of Health Services Policy & Practice

Post-doctoral Fellow 2013-2016 University of British Columbia, Department of Medicine (Neurology)

Research Assistant 2007-2013 University of British Columbia, Child & Family Research Institute

Data Analyst 2006-2007 University of British Columbia, Child & Family Research Institute

RESEARCH FUNDINGS Current Research Support

Assessing safety monitoring in patients taking oral multiple sclerosis treatments (ASYMPTOTE) Role: Co-PI (PI: Tremlett)

Multiple Sclerosis Society of Canada 10/01/2015 – 09/30/2018 A Clinical Prediction Tool to Guide Treatment of Osteoporosis in the Nursing Home

Role: Co-Investigator (PI: Berry)

NIA 09/30/14 - 09/30/18 Aging, comorbid conditions, and health care utilization in persons with HIV

Role: Co-Investigator (PI: Wilson)

(2)

Stratified Cluster Random Assignment Trial FluAd Role: Co-Investigator (PI: Mor)

Insight Therapeutics, LLC 10/01/16 – 09/30/18 High Dose Influenza Vaccination and Morbidity and Mortality ín U.S. Nursing Homes: Assessing cost-effectiveness and relative benefit compared to standard dose

Role: Co-Investigator (PI: Shireman)

Insight Therapeutics, LLC 12/31/16 – 12/31/17 Effectiveness of Medicaid's Home- and Community-Based Services for Persons with Multiple Sclerosis

Role: Co-Investigator (PI: Shireman)

National Multiple Sclerosis Society 10/01/14 - 09/30/17 Pending Research Supports

Use of Rehabilitation Services Following Lower Limb Fractures in Multiple Sclerosis (Rehabilitation-Fracture-MS)

Role: Principal Investigator

Submitted to NINDS 2017 Opioids use During Pregnancy and Health Outcomes in Mothers and Their Children (Opioids-Mothers-Children)

Role: Principal Investigator

Re-submitted to NIA 2017 Completed Research Supports

Impact of adherence to immunomodulatory therapies on MS progression

Postdoctoral Fellowship Award, Multiple Sclerosis Society of Canada Role: Co-Principal Investigator (PI: Tremlett/Evans) 2013–2016 Prescription drug use in patients with multiple sclerosis, Multiple Sclerosis Society of Canada Role: Co-investigator (PI: Tremlett) 2015 Asthma drug regimen optimality and health services utilizations: a population-based analysis Drug Safety and Effectiveness Cross-Disciplinary Training Award

Canadian Institutes of Health Research

Role: Co-Principal Investigator (PI: Tremlett) 2010–2011

PUBLICATIONS Peer-Reviewed Journal Papers

(3)

multiple sclerosis: a population-based analysis. Neurology. Epub. January 3, 2018, DOI: https://doi.org/10.1212/WNL.0000000000004885.

Zullo A.R., Zhang T, Banerjee G, Lee Y, McConeghy K.W., Kiel D. P., Daiello L.A., Mor V and Berry S.D. Facility and State Variation in Hip Fracture among US Nursing Home Residents. Journal of the American Geriatrics Society. In press. January 2018. DOI: 10.1111/jgs.15264. McKay K.A., Tremlett H, Fisk J.D., Zhang T, Patten S.B., Kastrukoff L. et al. Psychiatric comorbidity is associated with disability progression in multiple sclerosis. Neurology. In press. January 2018.

Zullo A.R., Zhang T, Beaudoin F, Lee Y, McConeghy K.W., Kiel D. P., Daiello L.A., Mor V and Berry S.D. Pain Treatments after Hip Fracture among Older Nursing Home Residents. JAMDA. 2017. Doi: 10.1016/j.jamda.2017.

Zhang T, Kingwell E, Zhu F, Petkau J, Kastrukoff L.F., Marrie R.A., Tremlett H and Evans C. Effects of adherence to the first-line injectable immunomodulatory drugs on disability

accumulation in multiple sclerosis: a longitudinal cohort study. BMJ Open.2017:7:e018612. doi: 10.1136/bmjopen-2017-018612.

Zhang T, Tremlett H, Tennakoon A, Leung S, Zhu F, Kingwell et al. Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis. Neurology.2016;86:1287-95.

Zhang T, Kingwell E, Hilda DJ, Zhu F, Zhao Y, Carruthers R et al. Association between selective serotonin reuptake inhibitors use and multiple sclerosis disability progression. Pharmacoepidemiology & Drug Safety. 2016;25(10):1150-1159.

Bardal S, Smith A, Luo H, Zhang T, Groeneweg G, Jimenez Mendez R et al. Asthma in British Columbia: are we finally breathing easier? A population-based study of the burden of disease over 14 years. Journal of Asthma. July 14, 2016:1-10.

Zhang T, Shirani A, Zhao Y, Ehsanul Karim M, Gustafson P and Petkau J et al. Exposure to beta-interferon and onset of secondary progressive multiple sclerosis. European Journal of Neurology. 2015; 22(6):990-1000.

Zhang T, Smith A, Camp P and Carleton B. High use of health services in patients with

suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada. Pharmacoepidemiology & Drug Safety. 2013 Jul;22(7):744-51.

Zhang T, Smith A, Camp P, MacLeod S and Carleton B. Prescription drug dispensing profiles for one million children: a population-based analysis. Eur J Clin Pharmacol. 2013

(4)

Camp P, Zhang T, Smith A and Carleton B. The use of long-acting beta2-agonists as monotherapy in children and adults. Journal of Population Therapeutics and Clinical Pharmacology. 2013;20(1):e1-e12.

Chawla J, Seear M, Zhang T, Smith A and Carleton B. Fifty years of pediatric asthma in developed countries: how reliable are the basic data sources? Pediatric Pulmonology. 2012;47(3):211-9.

Zhang T, Carleton B, Smith A and Prosser R. The Added Burden of Comorbidity in Patients with Asthma. Journal of Asthma. 2009;46(10):1021-6.

Conference Proceedings

Wong B, Cahill J, Bouley J, Daigle A, Zhang T and Rizvi S. Disability progression variability in different ages at diagnosis of multiple sclerosis. Multiple Sclerosis Journal. 2017 October. Wong B, Cahill J, Bouley J, Daigle A, Zhang T and Rizvi S. Disability and unemployment utilization in patients with multiple sclerosis. Multiple Sclerosis Journal. 2017 October. McKay K, Tremlett H, Fisk J.D., Zhang T, Kastrukoff L and Marrie R.A. Association between psychiatric comorbidity and disability progression of multiple sclerosis. Multiple Sclerosis Journal. 2017 October.

Setayeshgar S, Kingwell E, Zhu F, Zhang X.Y., Zhang T, Marrie R.A., Carruthers R. and Tremlett H. Use of the new oral disease-modifying therapies among the multiple sclerosis population in British Columbia, Canada over a five-year period (2011-2015). Multiple Sclerosis Journal. 2017 October.

Zullo A.R., Sharmin S., Daiello L.A., Zhang T and Shireman T.I. Dose- and Drug-Specific Effects of Sulfonylureas on Hypoglycemia and Cardiovascular Events in Older Nursing Home Residents. Pharmacoepidemiology and Drug Safety. 2017; 26 (S2).

Shireman T. I., Zhang T., Ogarek J. Medicaid Home- and Community-Based Service Utilization by People with Multiple Sclerosis. Journal of the American Geriatrics Society. 2017;65:S83. Shireman, T. I., Zhang, T.; Ogarek, J. State Variation in Medicaid Home- and Community-Based Services for People with Multiple Sclerosis. Journal of the American Geriatrics Society.

2017;65:S82-S83.

Zhang T, Tremlett H, Tennakoon A, Leung S, Zhu F, Kingwell et al. Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis. Neurology.

2016;Supplement 86 (16):185.

(5)

Pharmacoepidemiology and Drug Safety. 2011;20(S1):s253.

Zhang T, Smith A, Prosser R, and Carleton B. Asthma drug regimens and health service utilization: what impact do changes in the optimal use of medication have on children with asthma. Basic & Clinical Pharmacology & Toxicology. 2010;107(s1):s685.

Zhang T, Li Z, Smith A, Cao D, Carleton B. Pharmacoepidemiological studies in Chinese and Canadian children – lack of comprehensive data a major limitation. Basic & Clinical

Pharmacology & Toxicology. 2010;107(S1):s686.

Zhang T, Smith A, Camp P, Carleton B. Asthma Drug Regimens and Health Service Utilization: How Can We Improve Care? Am. J. Respir. Crit. Care Med. 2010; 181: A3125.

Zhang T, Carleton B, Smith A and Prosser R. Changing patterns of asthma patients’ medication regimens and health service utilization: a population-based study. Journal of Population

Therapeutics and Clinical Pharmacology. 2008;15(3):e744.

Prosser B, Carleton B, Smith A and Zhang T. Prescription medication utilization in British

Columbia’s pediatric population. Journal of Population Therapeutics and Clinical Pharmacology. 2008;15(3):e668.

INVITED PRESENTATIONS

Zhang T. Age-related co-morbidities in MS. American Academy of Neurology. Breakthroughs in Neurology. Orlando, Florida, January 2018.

Zhang T, Carleton B, Smith A and Prosser R. Drug Utilization in the Pediatric Population of British Columbia: A Comparison with a National Study. Third Annual Conference & AGM “Leaders, Innovators & Healers in Child and Youth Health Research, Vernon, British Columbia, Canada, November 2008.

OTHER PRESENTATIONS

Zhang T, Tremlett H, Tennakoon A, Leung S, Zhu F, Kingwell et al. Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis. The EndMS Conference, Toronto, Canada. December 2016.

Zhang T, Tremlett H, Tennakoon A, Leung S, Zhu F, Kingwell et al. Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis. The British Columbia MS/NMO Connect Presentation. June 2015.

Zhang T, Shirani A, Zhao Y, Ehsanul Karim M, Gustafson P and Petkau J et al. Beta-interferon exposure and onset of secondary progressive multiple sclerosis. The British Columbia MS/NMO Connect Presentation. April 2015.

(6)

HONORS AND AWARDS

Postdoctoral Fellowship Award, Multiple Sclerosis Society of Canada 2014–2016

Child & Family Research Institute Research Methodology Training Grant 2009

Canadian Association for Population Therapeutics Studentship Award 2008

University of British Columbia Entrance Scholarship 2007

British Columbia Child and Youth Health Research Network Internship 2007

British Columbia Medical Association Summer Research Scholarship 2006

Simon Fraser University Graduate fellowship 2005-2006 NON-ACADEMIC VOLUNTEER Coordinator of Pharmacoepidemiology Journal Club 2009–2010 Faculty of Pharmaceutical Sciences, University of British Columbia Program Assistant University of British Columbia, Child & Family Research Institute 2006

CERTIFICATE Certificate of Training in Course Design Intensive University of British Columbia, Canada 2015

Certificate of Training in Instructional Skills Workshops University of British Columbia, Canada 2010

Certificate of Training in Intermediate and Advanced Pharmacoepidemiology McGill University, Canada 2009

References

Related documents

control, with the specified power factor (see below) and the machine’s active power setting (PG on the data record) used to set the machine’s reactive power limits..  3 if this is

and invited their supervisors to participate in the study. We focused on one discipline as we wished to maintain homogeneity. The participants were from five leading universities

The Greensburg Diocesan Council of the Na- tional Council of Catholic Women, “Pray for Life Day” will be Friday, January 29, 2021 at Christ our Shepherd Center, Greensburg,

Generic chosen message attack : C obtains A’s signatures on.. messages selected without knowledge of A’s

The UAUIP condition implies that equilibrium in the for- eign exchange market is associated with an aggregate premium on foreign exchange — dubbed an equilibrium uncertainty premium

Central to this is the need for peace processes to be inclusive, this refers to both the inclusion of the main parties to the conflict, but also the inclusion of groups that

Produced with ScanToPDF

Figure 7 – Disc thickness variation showing third order component – 300°C, 1200r/min – heavy judder present Judder was present audibly and visibly via the analogue pressure